Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Adolor claims novel opioid antagonists for use in GI disorders

Nov. 9, 2004

New cathepsin S inhibitors in early development at Boehringer Ingelheim

Nov. 9, 2004

New elastase release inhibitors described by Taisho and U. of Texas scientists

Nov. 9, 2004

ARS scientists prepare and test novel amylin antiaggregatory peptides

Nov. 9, 2004

New chiral antiarrhythmic agent covered by Aventis patent

Nov. 9, 2004

Indian researchers isolate new cytotoxic terpenes from plants

Nov. 9, 2004

New PPARgamma activators and their use in type 2 diabetes and metabolic syndrome

Nov. 9, 2004

Shionogi scientists present new HIV integrase inhibitors

Nov. 8, 2004

Novel IgE production inhibitors prepared and tested at Dainippon

Nov. 8, 2004

Vertex patent covers novel GSK-3 inhibitors and their use in stroke, AD, diabetes, etc.

Nov. 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...